Oncogenic gene fusions can create neoantigens

How gene fusions could be targets for immunotherapy

Memorial Sloan Kettering Cancer Center researchers have identified gene fusions as a source of cancer neoantigens that could be targeted by immunotherapy.

As companies develop immunotherapies against neoantigens, research is increasingly looking beyond point mutations

Read the full 343 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE